Leeward Investments LLC MA Has $8.68 Million Stake in Innospec Inc. (NASDAQ:IOSP)

Leeward Investments LLC MA raised its position in Innospec Inc. (NASDAQ:IOSP) by 5.6% during the second quarter, according to its most recent filing with the SEC. The firm owned 70,254 shares of the specialty chemicals company’s stock after purchasing an additional 3,706 shares during the period. Leeward Investments LLC MA owned 0.28% of Innospec worth $8,683,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. TFO Wealth Partners LLC lifted its position in shares of Innospec by 29,800.0% during the 4th quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after acquiring an additional 298 shares during the period. GAMMA Investing LLC acquired a new position in shares of Innospec during the 4th quarter valued at $44,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Innospec during the 1st quarter valued at $66,000. CWM LLC lifted its position in shares of Innospec by 239.6% during the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after acquiring an additional 448 shares during the period. Finally, Motco acquired a new position in shares of Innospec during the 1st quarter valued at $132,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Down 0.0 %

IOSP traded down $0.03 during trading on Monday, hitting $108.76. 6,078 shares of the company’s stock were exchanged, compared to its average volume of 105,335. The business’s 50 day moving average is $121.97 and its two-hundred day moving average is $123.66. Innospec Inc. has a fifty-two week low of $95.69 and a fifty-two week high of $133.71. The stock has a market cap of $2.71 billion, a P/E ratio of 18.47 and a beta of 1.10.

Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.02. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The firm had revenue of $435.00 million for the quarter, compared to the consensus estimate of $468.73 million. During the same quarter in the prior year, the company posted $1.28 earnings per share. The business’s revenue was down 9.5% on a year-over-year basis. On average, sell-side analysts forecast that Innospec Inc. will post 5.95 earnings per share for the current year.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.